BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32042924)

  • 1. Pharmacokinetic and Pharmacodynamic Characterization of Tetrahydrocannabinol-Induced Cannabinoid Dependence After Chronic Passive Cannabis Smoke Exposure in Rats.
    Ravula A; Chandasana H; Jagnarine D; Wall SC; Setlow B; Febo M; Bruijnzeel AW; Derendorf H
    Cannabis Cannabinoid Res; 2019; 4(4):240-254. PubMed ID: 32042924
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats.
    Bruijnzeel AW; Qi X; Guzhva LV; Wall S; Deng JV; Gold MS; Febo M; Setlow B
    PLoS One; 2016; 11(4):e0153327. PubMed ID: 27065006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous quantification of cannabinoids tetrahydrocannabinol, cannabidiol and CB1 receptor antagonist in rat plasma: An application to characterize pharmacokinetics after passive cannabis smoke inhalation and co-administration of rimonabant.
    Ravula A; Chandasana H; Setlow B; Febo M; Bruijnzeel AW; Derendorf H
    J Pharm Biomed Anal; 2018 Oct; 160():119-125. PubMed ID: 30077950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of delta-9-tetrahydrocannabinol following acute cannabis smoke exposure in mice; effects of sex, age, and strain.
    Gazarov EA; Zequeira S; Senetra AS; Howard J; Sharma A; McCurdy CR; Lewis J; Bizon JL; Setlow B
    Front Pharmacol; 2023; 14():1227220. PubMed ID: 37701025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
    Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
    Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents.
    Manwell LA; Ford B; Matthews BA; Heipel H; Mallet PE
    J Pharmacol Toxicol Methods; 2014; 70(1):112-9. PubMed ID: 24956154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.
    van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive cannabis smoke exposure and oral fluid testing.
    Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop.
    Röhrich J; Schimmel I; Zörntlein S; Becker J; Drobnik S; Kaufmann T; Kuntz V; Urban R
    J Anal Toxicol; 2010 May; 34(4):196-203. PubMed ID: 20465865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing effects of acute exposure to cannabis smoke on working memory performance.
    Blaes SL; Orsini CA; Holik HM; Stubbs TD; Ferguson SN; Heshmati SC; Bruner MM; Wall SC; Febo M; Bruijnzeel AW; Bizon JL; Setlow B
    Neurobiol Learn Mem; 2019 Jan; 157():151-162. PubMed ID: 30521850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol.
    Cone EJ; Johnson RE; Darwin WD; Yousefnejad D; Mell LD; Paul BD; Mitchell J
    J Anal Toxicol; 1987; 11(3):89-96. PubMed ID: 3037193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of acute Cannabis smoke or Δ
    Barnard IL; Onofrychuk TJ; Sandini TM; McElroy DL; Zagzoog A; Roebuck AJ; Austin-Scott FV; Laprairie RB; Howland JG
    Neurobiol Learn Mem; 2022 Jul; 192():107624. PubMed ID: 35513236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaporized Delta-9-tetrahydrocannabinol Inhalation in Female Sprague Dawley Rats: A Pharmacokinetic and Behavioral Assessment.
    Penman SL; Berthold EC; Mihalkovic A; Hammond N; McCurdy CR; Blum K; Eiden RD; Sharma A; Thanos PK
    Curr Pharm Des; 2023; 29(27):2149-2160. PubMed ID: 37114788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users.
    Lee D; Bergamaschi MM; Milman G; Barnes AJ; Queiroz RH; Vandrey R; Huestis MA
    J Anal Toxicol; 2015 Oct; 39(8):580-7. PubMed ID: 26378131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
    Huestis MA; Cone EJ
    J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids in blood and urine after passive inhalation of Cannabis smoke.
    Mørland J; Bugge A; Skuterud B; Steen A; Wethe GH; Kjeldsen T
    J Forensic Sci; 1985 Oct; 30(4):997-1002. PubMed ID: 2999292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part I: development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents.
    Manwell LA; Charchoglyan A; Brewer D; Matthews BA; Heipel H; Mallet PE
    J Pharmacol Toxicol Methods; 2014; 70(1):120-7. PubMed ID: 24973534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
    Katsidoni V; Kastellakis A; Panagis G
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent mice.
    Wilson DM; Varvel SA; Harloe JP; Martin BR; Lichtman AH
    Pharmacol Biochem Behav; 2006 Sep; 85(1):105-13. PubMed ID: 16934319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.